Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Sees Large Decline in Short Interest

Sartorius Aktiengesellschaft (OTCMKTS:SARTFGet Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 1,600 shares, a decline of 52.9% from the May 15th total of 3,400 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 16.0 days. Currently, 0.0% of the shares of the stock are sold short.

Sartorius Aktiengesellschaft Price Performance

OTCMKTS:SARTF remained flat at $198.80 during trading hours on Friday. The company has a quick ratio of 1.13, a current ratio of 2.02 and a debt-to-equity ratio of 1.17. The stock’s fifty day moving average price is $197.91 and its 200 day moving average price is $198.57. The company has a market capitalization of $6.80 billion, a PE ratio of 150.61 and a beta of 1.09. Sartorius Aktiengesellschaft has a twelve month low of $165.00 and a twelve month high of $243.35.

Sartorius Aktiengesellschaft (OTCMKTS:SARTFGet Free Report) last released its quarterly earnings results on Wednesday, April 16th. The company reported $1.28 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.28. The business had revenue of $959.23 million during the quarter, compared to analysts’ expectations of $867.08 million. Sartorius Aktiengesellschaft had a return on equity of 7.33% and a net margin of 2.48%.

Analysts Set New Price Targets

Separately, DZ Bank upgraded Sartorius Aktiengesellschaft from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 17th.

Read Our Latest Analysis on Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft Company Profile

(Get Free Report)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

Further Reading

Receive News & Ratings for Sartorius Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.